Letrozole

Product NDC: 60505-3255
11-digit product format: 605053255
Labeler code: 60505
Product ID: 60505-3255_e055b181-3341-1886-a9c1-0c552a9a18a3
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Letrozole
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Apotex Corp.
Application: ANDA091303
Marketing category: ANDA
Marketing start: 2012-05-31
Marketing end: 2021-12-31
Substance: LETROZOLE
Active strength: 3 mg/1
Pharmacologic classes: Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	60505-3255		D	Discontinued by firm	2026-08-17
excluded package	package	60505-3255	60505-3255-1	D	Discontinued by firm	2026-08-17
excluded package	package	60505-3255	60505-3255-3	D	Discontinued by firm	2026-08-17
excluded package	package	60505-3255	60505-3255-8	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	60505-3255-3	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	60505-3255-8	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	60505-3255-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	60505-3255-3	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	60505-3255-8	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	60505-3255-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	60505-3255-3	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	60505-3255-8	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	60505-3255-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	60505-3255-3	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	60505-3255-8	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	60505-3255-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	60505-3255-3	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	60505-3255-8	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	60505-3255-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	60505-3255-3	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	60505-3255-8	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	60505-3255-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	60505-3255-3	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	60505-3255-8	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	60505-3255-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	60505-3255-3	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	60505-3255-8	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	60505-3255-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	60505-3255-3	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	60505-3255-8	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	60505-3255-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	60505-3255-3	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	60505-3255-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	60505-3255-8	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	60505-3255-3	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	60505-3255-1	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	60505-3255-8	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	60505-3255-3	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	60505-3255-1	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	60505-3255-8	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A091303-001	LETROZOLE	LETROZOLE	2.5MG	TABLET / ORAL			2012-04-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL	AB	2012-04-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL	AB	2012-04-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL	AB	2012-04-19	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL	AB	2012-04-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL	AB	2012-04-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL	AB	2012-04-19	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A091303-001	LETROZOLE	2.5MG	TABLET / ORAL		2012-04-19	`e64feba35796…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A091303-001	AB	1	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	A091303-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A091303-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A091303-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A091303-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A091303-001	AB	1	`ea99ee380514…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
60505-3255-3	EA - Each	60505-3255	7d6b26f4-9c68-4e15-a5c1-d78846e4741e	1	2012-07-24
60505-3255-8	EA - Each	60505-3255	7f31f39a-e760-4e45-9390-950de6516ee4	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LETROZOLE	ACTIVE INGREDIENT	7LKK855W8I	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4
LETROZOLE	ACTIVE MOIETY	7LKK855W8I	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4
POLYETHYLENE GLYCOL 8000	INACTIVE INGREDIENT	Q662QK8M3B	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LETROZOLE TABLET, FILM COATED [APOTEX CORP.]	4

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LKK855W8I	LETROZOLE	112809-51-5	LETROZOLE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
60505-3255-3	60505325503	30 TABLET, FILM COATED in 1 BOTTLE (60505-3255-3)	2012-05-31	2021-12-31	No	No	Current